Chevron Decision by Supreme Court May Help Protect Pain Prescribers from Federal Overreach MD LabsOctober 28, 2024
With Ketamine Therapies on the Rise, Definitive Ketamine Metabolite Testing is Gaining Importance in Patient Monitoring by Prescribers MD LabsOctober 21, 2024
September is Pain Awareness Month: How MD Labs Supports Providers Using Precision Patient Monitoring and Pharmacogenetics Testing MD LabsSeptember 20, 2024
Chronic Pain Specialists: New Medicare "G" Codes G3002 & G3003: Essential Information for Providers MD LabsAugust 26, 2024
Balancing the Genetic and Environmental Factors in Opioid Dependence: Insights for Healthcare Providers MD LabsAugust 21, 2024
Consensus Guidelines Published for Assessing Pain in Rural Pain Management Patient Populations MD LabsJuly 1, 2024
Patients and Physicians Take to Social Media to Get Payers to Cover Laboratory Testing MD LabsSeptember 26, 2023
National Opioid Awareness Day: MD Labs' Pragmatic Approach to the Opioid Crisis MD LabsAugust 31, 2023
Empowering Physicians: Expedited Diagnostics, Simplified Reports, and Seamless Integration with MD Labs MD LabsAugust 15, 2023
From Medical Marvel to Looming Crisis: The History and Current State of Methamphetamine Use MD LabsJuly 13, 2023
